EMA and HMA to strengthen Anti-D Immunoglobulin supply chain
These medicines are essential in preventing RhD immunisation during pregnancy
These medicines are essential in preventing RhD immunisation during pregnancy
Commercial production is expected to begin soon
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Lijo Chacko is the Chief Executive Officer – Middle East & Africa at Sigachi Industries
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
The facility will manufacture 13,200 MTPA Benzyl Chloride, 9,600 MTPA Benzyl Alcohol, and 7,200 MTPA Benzaldehyde
The audit has been concluded with no major observations
Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the Imfinzi regimen vs. neoadjuvant chemotherapy alone
Subscribe To Our Newsletter & Stay Updated